215 related articles for article (PubMed ID: 32127099)
1. Leveraging differentiated HIV service delivery to expand tuberculosis preventive treatment: a call to action.
Rabkin M; Howard AA; Ehrenkranz P; Fernandez LG; Preko P; Singh V; Tomlinson HL; El-Sadr WM
Int J Tuberc Lung Dis; 2020 Feb; 24(2):165-169. PubMed ID: 32127099
[TBL] [Abstract][Full Text] [Related]
2. New opportunities in tuberculosis prevention: implications for people living with HIV.
González Fernández L; Casas EC; Singh S; Churchyard GJ; Brigden G; Gotuzzo E; Vandevelde W; Sahu S; Ahmedov S; Kamarulzaman A; Ponce-de-León A; Grinsztejn B; Swindells S
J Int AIDS Soc; 2020 Jan; 23(1):e25438. PubMed ID: 31913556
[TBL] [Abstract][Full Text] [Related]
3. Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis.
Uppal A; Rahman S; Campbell JR; Oxlade O; Menzies D
PLoS Med; 2021 Sep; 18(9):e1003712. PubMed ID: 34520463
[TBL] [Abstract][Full Text] [Related]
4. Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness.
Nsengiyumva NP; Campbell JR; Oxlade O; Vesga JF; Lienhardt C; Trajman A; Falzon D; Den Boon S; Arinaminpathy N; Schwartzman K
PLoS Med; 2022 Jun; 19(6):e1004032. PubMed ID: 35696431
[TBL] [Abstract][Full Text] [Related]
5. Tuberculosis preventive treatment uptake among people living with HIV during COVID-19 period in Addis Ababa, Ethiopia: a retrospective data review.
Gebreegziabher SB; Ashuro AA; Kumssa TH; Teferi MY; Alemayue EA; Datiko DG; Yimer SA; Shagre MB
BMC Infect Dis; 2024 May; 24(1):499. PubMed ID: 38760665
[TBL] [Abstract][Full Text] [Related]
6. Tuberculosis screening improves preventive therapy uptake (TB SCRIPT) trial among people living with HIV in Uganda: a study protocol of an individual randomized controlled trial.
Semitala FC; Chaisson LH; Dowdy DW; Armstrong DT; Opira B; Aman K; Kamya M; Phillips PPJ; Yoon C
Trials; 2022 May; 23(1):399. PubMed ID: 35550621
[TBL] [Abstract][Full Text] [Related]
7. Implementing TB preventive treatment within differentiated HIV service delivery models in global programs.
Boyd AT; Moore B; Shah M; Tran C; Kirking H; Cavanaugh JS; Al-Samarrai T; Pathmanathan I
Public Health Action; 2020 Sep; 10(3):104-110. PubMed ID: 33134124
[TBL] [Abstract][Full Text] [Related]
8. TB preventive therapy for people living with HIV: key considerations for scale-up in resource-limited settings.
Pathmanathan I; Ahmedov S; Pevzner E; Anyalechi G; Modi S; Kirking H; Cavanaugh JS
Int J Tuberc Lung Dis; 2018 Jun; 22(6):596-605. PubMed ID: 29862942
[TBL] [Abstract][Full Text] [Related]
9. Integrating 3HP-based tuberculosis preventive treatment into Zimbabwe's Fast Track HIV treatment model: experiences from a pilot study.
Mapingure MP; Zech JM; Hirsch-Moverman Y; Msukwa M; Howard AA; Makoni T; Gwanzura C; Apollo T; Sandy C; Musuka GN; Rabkin M
J Int AIDS Soc; 2023 Jun; 26(6):e26105. PubMed ID: 37339341
[TBL] [Abstract][Full Text] [Related]
10. Assessing the impact of antiretroviral therapy on tuberculosis notification rates among people with HIV: a descriptive analysis of 23 countries in sub-Saharan Africa, 2010-2015.
Surie D; Borgdorff MW; Cain KP; Click ES; DeCock KM; Yuen CM
BMC Infect Dis; 2018 Sep; 18(1):481. PubMed ID: 30257667
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the uptake of tuberculosis preventative therapy for people living with HIV in Namibia: a multiple methods analysis.
Roscoe C; Lockhart C; de Klerk M; Baughman A; Agolory S; Gawanab M; Menzies H; Jonas A; Salomo N; Taffa N; Lowrance D; Robsky K; Tollefson D; Pevzner E; Hamunime N; Mavhunga F; Mungunda H
BMC Public Health; 2020 Dec; 20(1):1838. PubMed ID: 33261569
[TBL] [Abstract][Full Text] [Related]
12. The latent tuberculosis cascade-of-care among people living with HIV: A systematic review and meta-analysis.
Bastos ML; Melnychuk L; Campbell JR; Oxlade O; Menzies D
PLoS Med; 2021 Sep; 18(9):e1003703. PubMed ID: 34492003
[TBL] [Abstract][Full Text] [Related]
13. Derivation and external validation of a risk score for predicting HIV-associated tuberculosis to support case finding and preventive therapy scale-up: A cohort study.
Auld AF; Kerkhoff AD; Hanifa Y; Wood R; Charalambous S; Liu Y; Agizew T; Mathoma A; Boyd R; Date A; Shiraishi RW; Bicego G; Mathebula-Modongo U; Alexander H; Serumola C; Rankgoane-Pono G; Pono P; Finlay A; Shepherd JC; Ellerbrock TV; Grant AD; Fielding K
PLoS Med; 2021 Sep; 18(9):e1003739. PubMed ID: 34491987
[TBL] [Abstract][Full Text] [Related]
14. Preventive therapy for HIV-associated tuberculosis.
Durovni B; Cavalcante S
Curr Opin HIV AIDS; 2018 Nov; 13(6):507-511. PubMed ID: 30286041
[TBL] [Abstract][Full Text] [Related]
15. Challenges and opportunities to prevent tuberculosis in people living with HIV in low-income countries.
Harries AD; Schwoebel V; Monedero-Recuero I; Aung TK; Chadha S; Chiang CY; Conradie F; Dongo JP; Heldal E; Jensen P; Nyengele JPK; Koura KG; Kumar AMV; Lin Y; Mlilo N; Nakanwagi-Mukwaya A; Ncube RT; Nyinoburyo R; Oo NL; Patel LN; Piubello A; Rusen ID; Sanda T; Satyanarayana S; Syed I; Thu AS; Tonsing J; Trébucq A; Zamora V; Zishiri C; Hinderaker SG; Aït-Khaled N; Roggi A; Caminero Luna J; Graham SM; Dlodlo RA; Fujiwara PI
Int J Tuberc Lung Dis; 2019 Feb; 23(2):241-251. PubMed ID: 30808459
[TBL] [Abstract][Full Text] [Related]
16. Preventing tuberculosis with community-based care in an HIV-endemic setting: a modelling analysis.
Ross JM; Greene C; Broshkevitch CJ; Dowdy DW; van Heerden A; Heitner J; Rao DW; Roberts DA; Shapiro AE; Zabinsky ZB; Barnabas RV
J Int AIDS Soc; 2024 Jun; 27(6):e26272. PubMed ID: 38861426
[TBL] [Abstract][Full Text] [Related]
17. Tuberculosis treatment within differentiated service delivery models in global HIV/TB programming.
Tran CH; Moore BK; Pathmanathan I; Lungu P; Shah NS; Oboho I; Al-Samarrai T; Maloney SA; Date A; Boyd AT
J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25809. PubMed ID: 34713974
[TBL] [Abstract][Full Text] [Related]
18. Brief Report: Programmatic Scale-up of Tuberculosis Preventive Treatment Among People Living With HIV Through Targeted Technical Assistance to High-Volume Antiretroviral Treatment Sites-Nigeria, 2018-2019.
Boyd AT; Odume B; Sidibe K; Onotu D; Ogbanufe O; Mgbakor I; Swaminathan M
J Acquir Immune Defic Syndr; 2020 Dec; 85(4):450-453. PubMed ID: 33136743
[TBL] [Abstract][Full Text] [Related]
19. Use of isoniazid preventive therapy for tuberculosis prophylaxis among people living with HIV/AIDS: a review of the literature.
Briggs MA; Emerson C; Modi S; Taylor NK; Date A
J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3(Suppl 3):S297-305. PubMed ID: 25768869
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
